tiprankstipranks
Advertisement
Advertisement
PremiumRatingsBuy Rating on Generate Biomedicines Driven by Differentiated Pipeline, GB-0895 Asthma Opportunity, and AI-Enabled Protein Platform
3M ago
Premium
Ratings
Generate Biomedicines: Differentiated AI-Driven Protein Platform with GB-0895 Asthma Lead and Emerging Oncology Upside Justifies Buy Rating
3M ago
Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Generate Biomedicines initiated with an Overweight at Cantor Fitzgerald
3M ago
Generate Biomedicines initiated with a Buy at Goldman Sachs
PremiumThe FlyGenerate Biomedicines initiated with a Buy at Goldman Sachs
3M ago
Opening Day: Janus Living opens at $23.50 after upsized IPO
Premium
The Fly
Opening Day: Janus Living opens at $23.50 after upsized IPO
3M ago
Opening Day: Generate Biomedicines makes public debut
Premium
The Fly
Opening Day: Generate Biomedicines makes public debut
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100